Filed: 11/14/2025ACC: 0000902664-25-005031
📋 What this filing means
72 INVESTMENT HOLDINGS, LLC filed this quarterly 13F‑HR report disclosing 5 equity positions with a total reported market value of $67.95M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
5
Positions
$67.95M
Total AUM (reported)
2.50M
Total Shares
Allocation by class
COM$61.77M90.9%
COM NEW$3.49M5.1%
COM SHS$2.68M4.0%
Portfolio Concentration
Top 3$64.16M94.4%
4–10$3.79M5.6%
Top 3 weight
94.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 2.50M
Sole
Full voting authority
0.00
shares
% of voting shares0.0%
Shared
Joint voting authority
2.50M
shares
% of voting shares100.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole0
Shared0
Other5
Dominant voting typeShared · 100.0% of voting shares
Institutional Holdings5
Rows:
LENZ THERAPEUTICS INC
DFNDShares1.02M
TypeSH
Market value$47.41M
69.77%
Sole
0.00
Shared
1.02M
None
0.00
KORRO BIO INC
DFNDShares276.83K
TypeSH
Market value$13.26M
19.51%
Sole
0.00
Shared
276.83K
None
0.00
PRAXIS PRECISION MEDICINES I
DFNDShares65.93K
TypeSH
Market value$3.49M
5.14%
Sole
0.00
Shared
65.93K
None
0.00
ALTO NEUROSCIENCE INC
DFNDShares667.78K
TypeSH
Market value$2.68M
3.95%
Sole
0.00
Shared
667.78K
None
0.00
CARIBOU BIOSCIENCES INC
DFNDShares474.07K
TypeSH
Market value$1.10M
1.63%
Sole
0.00
Shared
474.07K
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
LENZ THERAPEUTICS INCDFND | COM | 1.02M | SH | $47.41M 69.77% | 0.00 | 1.02M | 0.00 |
KORRO BIO INCDFND | COM | 276.83K | SH | $13.26M 19.51% | 0.00 | 276.83K | 0.00 |
PRAXIS PRECISION MEDICINES IDFND | COM NEW | 65.93K | SH | $3.49M 5.14% | 0.00 | 65.93K | 0.00 |
ALTO NEUROSCIENCE INCDFND | COM SHS | 667.78K | SH | $2.68M 3.95% | 0.00 | 667.78K | 0.00 |
CARIBOU BIOSCIENCES INCDFND | COM | 474.07K | SH | $1.10M 1.63% | 0.00 | 474.07K | 0.00 |